Scholars Central

Rapid communicationPublished 29 May 2025

Crystal Engineering for Optimized Drug Performance

Authors: Arjun Mehta

Process Optimization Group, Indian Institute of Chemical Technology, India

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Optimizing drug performance relies on precise control of pharmaceutical solid forms. Crystal engineering enables manipulation of crystal structures to enhance solubility, stability, and efficacy. Polymorphism, the existence of multiple crystalline forms, critically impacts these properties, necessitating careful selection of the most stable polymorph to ensure consistent drug performance and prevent bioavailability issues. Innovative strategies like pharmaceutical cocrystals and amorphous solid dispersions improve solubility and bioavailability. Additionally, hydrates and solvates influence drug properties through incorporated solvent molecules. Managing these solid forms, including polymorphic transformations, is paramount for consistent quality and therapeutic effectiveness.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Molecular Pharmaceutics & Organic Process Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Molecular Pharmaceutics & Organic Process Research
  • SubjectPharmaceutical Sciences
  • SubjectChemistry
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Arjun Mehta”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels